Locations
Rockville, MD, USA
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Other
founded in
2005
Cellphire Therapeutics is a fast-growing biotechnology company focused on saving lives through the development of innovative hemostatic products. Their key offerings include Thrombosomes® (FPH) and Cryopreserved Platelets (CPP), both of which are in Phase 2 clinical trials. These products provide significant advantages over traditional liquid stored platelets, including extended shelf life, consistent quality, and scalable production. With a commitment to transforming transfusion medicine, Cellphire aims to address critical needs in bleeding treatment and has established partnerships to enhance their product development and clinical manufacturing processes.
Something looks off?